Efficacy and safety of switching from reference adalimumab to SB5 in a real-life cohort of inflammatory rheumatic joint diseases
Sign Up to like & getrecommendations! Published in 2020 at "Clinical Rheumatology"
DOI: 10.1007/s10067-020-05199-w
Abstract: Objective SB5 showed comparable efficacy and safety profile in respect to adalimumab originator (ADA) in randomized clinical trials of rheumatoid arthritis (RA) and psoriasis. We aimed to describe the efficacy and safety of SB5 after… read more here.
Keywords: adalimumab; efficacy safety; safety; sb5 ... See more keywords
The oxidation state and coordination environment of antimony in silicate glasses
Sign Up to like & getrecommendations! Published in 2019 at "Chemical Geology"
DOI: 10.1016/j.chemgeo.2019.06.017
Abstract: Abstract Antimony K-edge X-ray absorption near edge structure (XANES) spectra were recorded for Sb in glasses of five synthetic CaO-MgO-Al2O3-SiO2 (CMAS) compositions and a simplified mid-ocean ridge basalt (MORB). The glasses were quenched from melts… read more here.
Keywords: silicate; coordination; sb5; state ... See more keywords
A switch from originator-adalimumab to the biosimilar SB5 in patients with Crohn’s disease: an analysis of two propensity score-matched cohorts
Sign Up to like & getrecommendations! Published in 2022 at "Scandinavian Journal of Gastroenterology"
DOI: 10.1080/00365521.2022.2041082
Abstract: Abstract Background/aims Originator-adalimumab, an established treatment for patients with Crohn’s disease (CD), showed no difference in efficacy or adverse events versus adalimumab biosimilar SB5 (SB5-adalimumab) over 10 weeks (W) of treatment. To understand the long-term… read more here.
Keywords: sb5; treatment; originator adalimumab; sb5 adalimumab ... See more keywords
Effectiveness of SB5, an Adalimumab Biosimilar, in Patients With Noninfectious Uveitis: A Real-Life Monocentric Experience
Sign Up to like & getrecommendations! Published in 2021 at "Asia-Pacific Journal of Ophthalmology"
DOI: 10.1097/apo.0000000000000380
Abstract: Purpose: Several concerns have arisen with biosimilars in terms of immunogenicity, safety issues, loss of efficacy, and extrapolation to other indications. The study aim was to evaluate the efficacy of SB5, an adalimumab biosimilar, in… read more here.
Keywords: last follow; noninfectious uveitis; uveitis relapses; sb5 ... See more keywords